Viveve Medical Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 6.9yrs |
| Board average tenure | no data |
Recent management updates
Recent updates
Viveve to get US patent for technology to treat female stress urinary incontinence
Oct 04Viveve Medical receives patent for dual-energy technology in Taiwan
Jul 12Viveve under pressure after upsizes capital raise, prices offering at $3.40
Jan 14Viveve regains compliance with Nasdaq
Dec 17Viveve jumps 19% after FDA clearance for expansion of manufacturing treatment tips
Dec 03CEO
Viveve Medical has no CEO, or we have no data on them.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Senior VP of Finance & Administration and Principal Accounting & Financial Officer | 7.4yrs | US$701.05k | no data | |
| Senior Advisor to the CEO & Director | 6.6yrs | US$208.88k | no data | |
| Vice President of Research | 6.9yrs | no data | no data | |
| Senior Director of Corporate Communications | no data | no data | no data | |
| Vice President of International Sales | no data | no data | no data | |
| Vice President of Global Marketing | no data | no data | no data | |
| Vice President of Human Resources | 7.6yrs | no data | no data | |
| Senior Vice President of Regulatory & Quality Affairs | 6.9yrs | no data | no data |
6.9yrs
Average Tenure
66yo
Average Age
Experienced Management: VIVE's management team is seasoned and experienced (6.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 13:48 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2022/09/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Viveve Medical, Inc. is covered by 14 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Benjamin Haynor | Alliance Global Partners |
| Gregory Chodaczek | B. Riley Securities, Inc. |
| Matthew Hewitt | Craig-Hallum Capital Group LLC |